Continuing Education Activity

Breathing, or pulmonary respiration, is the movement of air into and out of the lungs. The process relies on the coordinated function of the respiratory muscles, neural input from the brainstem respiratory centers, and continuous feedback from chemoreceptors and mechanoreceptors that regulate the rate and depth of breathing. Normal respiration maintains adequate alveolar ventilation, enabling oxygen to enter the pulmonary capillaries while expelling carbon dioxide. Abnormal respiration refers to any disturbance in rate, rhythm, depth, or effort that signals an underlying physiological abnormality. Such changes may reflect a compensatory response to stress or damage to one or more components of the respiratory system. A precisely regulated balance within the body sustains efficient respiration, ensuring sufficient oxygen delivery for cellular energy production and facilitating carbon dioxide removal to preserve acid-base homeostasis. Disorders that disrupt this balance impair gas exchange, leading to hypoxia, hypercapnia, and related disturbances in blood pH. These disturbances may present as dyspnea, fatigue, altered mental status, or, in severe cases, coma and death.

This activity for healthcare professionals is designed to enhance the learner's understanding of the physiology underlying normal and abnormal breathing patterns and their clinical significance. By navigating the intricacies of abnormal respirations, participants can optimize patient care and enhance healthcare outcomes. Greater proficiency increases the learner's ability to collaborate within an interprofessional team caring for patients with abnormal respirations.

Objectives:

• Identify abnormal breathing patterns and link each to potential underlying pathophysiology.
• Apply evidence-based interventions tailored to specific abnormal breathing patterns to optimize patient outcomes.
• Differentiate among abnormal respiratory patterns by recognizing unique diagnostic features to guide targeted treatment.
• Collaborate with interdisciplinary team members to optimize respiratory care and patient outcomes.

Introduction

Respiration is a vital physiological process that facilitates the exchange of gases between the body and the external environment. A carefully balanced system exists, involving multiple organs that work in concert to ensure adequate oxygen delivery for cellular energy production and the efficient elimination of carbon dioxide. Within the central nervous system, specialized respiratory centers integrate neural and chemical signals from peripheral and central receptors. These centers coordinate the activity of the respiratory muscles, maintaining upper airway patency and driving thoracic movements to regulate ventilation.[1] In addition to supporting gas exchange, respiration plays a central role in maintaining acid-base homeostasis and overall metabolic stability.

Although breathing typically occurs effortlessly and automatically, it remains highly susceptible to disruption. Disorders affecting the brain, lungs, airways, neuromuscular apparatus, or metabolic function can alter respiratory rate, rhythm, depth, or effort, compromising oxygenation and ventilation. Because abnormal respiratory patterns often reflect underlying systemic, neurologic, or metabolic disease, they serve as important diagnostic clues for clinicians. Recognizing these patterns and understanding their physiological basis are essential for accurate assessment, early intervention, and prevention of respiratory failure.

Function

Physiology of Breathing

Eupnea refers to normal, unlabored, and rhythmic breathing at rest. In healthy adults, the respiratory rate typically ranges from 12 to 20 breaths/min, with a tidal volume of approximately 500 mL per breath.[2] The respiratory rate of infants and children varies by age.

Disorders of respiration may arise from abnormalities in any part of the respiratory system, including the airways, alveoli, central and peripheral nervous systems, chest wall, and respiratory musculature. Abnormal breathing patterns often reflect derangements in physiological balance, such as blood pH (acidosis or alkalosis), carbon dioxide (hypercapnia or hypocapnia), and oxygen levels (hypoxia).[3] Minute ventilation, calculated as respiratory rate multiplied by tidal volume, is regulated by chemoreceptors sensitive to changes in arterial oxygen (PaO₂) and carbon dioxide (PaCO₂) levels. When these values are abnormal, compensatory mechanisms are activated, typically increasing the rate or depth of breathing to maintain adequate oxygenation and acid-base equilibrium. The respiratory centers in the medulla oblongata and pons coordinate these responses, adjusting ventilation automatically to meet the body's metabolic demands.[4]

Neural Control of Respiration

The medullary respiratory centers, the dorsal and ventral respiratory groups, generate the rhythmic pattern of breathing. The dorsal respiratory group consists mainly of inspiratory neurons that integrate sensory input and transmit signals to the phrenic and intercostal motor neurons, initiating inspiration. The ventral respiratory group contains both inspiratory and expiratory neurons, including the pre-Bötzinger complex, which is critical for generating the rhythmic breathing pattern. This group is also essential for modulating both inspiration and expiration during increased ventilatory demand, such as exercise or respiratory distress.[5] The pontine centers (pneumotaxic and apneustic) fine-tune this rhythm, ensuring a smooth transition between inhalation and exhalation.[6]

Peripheral chemoreceptors located in the carotid and aortic bodies respond rapidly to decreases in PaO₂ and pH. In contrast, central chemoreceptors within the medulla are highly sensitive to changes in PaCO₂ and cerebrospinal fluid pH. Pulmonary stretch receptors within the airway smooth muscle provide mechanical feedback to the medulla through the vagus nerve. The activation of pulmonary stretch receptors during lung inflation inhibits further inspiration via the Hering-Breuer reflex, preventing overexpansion of the lungs and modulating tidal volume during deep or labored breathing. Irritant receptors, located in the airway epithelium, respond to mechanical or chemical stimuli such as dust or cold air, briefly causing bronchoconstriction and reflexive shallow breathing that protect the airways. Juxtacapillary receptors, situated near alveolar capillaries, sense increased interstitial pressure or pulmonary congestion and can induce rapid, shallow breathing. The cerebral cortex and limbic system exert voluntary and emotional influences on respiration, allowing conscious control, as observed in speech or breath-holding, and modulating autonomic function during stress or anxiety. Together, these feedback systems maintain homeostatic control of ventilation.

Mechanics of Respiration

The interplay of lung compliance, airway resistance, and muscular effort determines the mechanics of ventilation. Together, these parameters determine the pressure required to move air into and out of the lungs. Lung compliance refers to the distensibility of the lung and chest wall, defined as the change in lung volume per unit change in transpulmonary pressure. High compliance means the lungs expand easily, whereas low compliance, as in pulmonary fibrosis or acute respiratory distress syndrome, requires greater pressure for the same volume change. The elastic properties of lung tissue, surface tension, and chest wall mechanics influence compliance.

Airway resistance, calculated as the ratio of pressure difference to airflow (ΔP/ΔV), is the opposition to airflow within the respiratory tract and is primarily determined by airway diameter and flow characteristics. Increased resistance, as observed in asthma or chronic obstructive pulmonary disease (COPD), means more pressure is needed to achieve a given airflow, and resistance is highest in the medium-sized bronchi.

Muscular effort refers to the force generated by respiratory muscles, mainly the diaphragm and intercostals, to overcome both compliance and airway resistance. During quiet breathing, muscular effort is modest, but it increases substantially during exercise, respiratory distress, or disease states with reduced compliance or increased resistance. The total work of breathing is the sum of the work to overcome elastic and resistive loads.

Pathophysiology of Abnormal Respirations

Abnormal respirations may occur from disruptions at any level of the respiratory control system. Disturbances may originate from central neural dysfunction, impaired neuromuscular transmission, structural abnormalities of the chest wall or lungs, or metabolic and biochemical imbalances that alter the body's ventilatory drive. Central nervous system disorders, such as stroke, trauma, hypoxic injury, or intracranial hypertension, can impair the medullary and pontine respiratory centers, leading to irregular or pathological breathing patterns. Peripheral and neuromuscular disorders, including amyotrophic lateral sclerosis, Guillain-Barré syndrome, and myasthenia gravis, impair respiratory muscle strength and coordination, leading to hypoventilation, hypercapnia, and ultimately respiratory failure.

Pulmonary and mechanical conditions, such as airway obstruction, restrictive lung disease, or chest wall deformity, alter compliance and resistance, increasing the work of breathing and reducing ventilation efficiency.

Metabolic derangements also profoundly influence respiration. Acidosis stimulates hyperventilation, whereas alkalosis or sedative toxicity may suppress ventilatory drive, leading to hypoventilation. Finally, psychogenic and behavioral factors, including anxiety and panic disorders, can produce functional hyperventilation syndromes. At the same time, agonal breathing and terminal patterns reflect failure of brainstem respiratory centers during critical illness or cardiac arrest. Understanding the pathophysiologic basis of abnormal respirations enables clinicians to interpret breathing patterns as diagnostic clues, guiding timely recognition, intervention, and stabilization of the underlying disorder.

Issues of Concern

Any alteration in the normal breathing pattern requires prompt clinical evaluation and intervention. Respiratory rate is one of the most sensitive indicators of physiologic deterioration. A rate greater than 25 breaths/min independently predicts increased mortality in hospital settings.[7] A comprehensive assessment begins with a detailed history, including symptoms, environmental exposures, comorbidities, and medication use. On physical examination, observing respiratory rate and pattern, along with auscultating breath sounds, provides key diagnostic clues. Diminished breath sounds may suggest airflow limitation, an effusion, or consolidation, whereas added sounds, such as crackles or rales, indicate fluid or infection. Wheeze and stridor typically reflect airway obstruction.[8]

Disordered respiration can be distressing and debilitating, significantly reducing quality of life. Impaired gas exchange results in hypoxemia and hypercapnia, leading to dyspnea, fatigue, and decreased exercise tolerance.[9] The chronic nature of respiratory disease often contributes to anxiety, depression, and fear of breathlessness, further compounding functional decline. Implementing evidence-based treatment and lifestyle modifications is therefore essential to improving both prognosis and quality of life.[10] Despite their impact, respiratory symptoms remain highly prevalent. Cardiac conditions, among the leading causes of death in the United States, commonly present with dyspnea as an early symptom. Obstructive lung diseases, including asthma and COPD, affect approximately 28 million and 16 million Americans, respectively. However, COPD is frequently underdiagnosed.[10] Globally, asthma affects 15% to 20% of individuals in developed nations and 2% to 4% in less developed regions, underscoring the widespread burden of respiratory dysfunction.

Clinical Significance

Clinically Significant Abnormal Respiratory Patterns

Disorders of respiratory rate: Abnormalities in respiratory rate can indicate underlying physiological, metabolic, or pathological disturbances and are critical for early detection and management.

• Bradypnea: An abnormally slow respiratory rate, typically fewer than 12 breaths/min in adults. Common causes include sedative or opioid use, hypothyroidism, alcohol intoxication, and traumatic brain injury.
• Tachypnea: An abnormally rapid respiratory rate, greater than 20 breaths/min in adults. Some potential etiologies include exercise, anxiety, infection, metabolic acidosis, sepsis, pulmonary embolism, lung disease, and cardiac dysfunction.
• Hyperpnea: An increased depth and rate of breathing in proportion to metabolic demand. Hyperpnea is a physiological response to exercise, fever, or increased metabolic rate and differs from hyperventilation, as blood gas values remain within normal limits.
• Hypoventilation: Shallow or slow breathing that reduces alveolar ventilation, leading to hypoxemia and hypercapnia. Hypoventilation may result from respiratory diseases, such as COPD or sleep apnea; central nervous system depression; medications, such as opioids; or neuromuscular disorders affecting respiratory muscles.
• Hyperventilation: Increased rate and depth of breathing beyond metabolic requirements, causing hypocapnia and respiratory alkalosis. Hyperventilation can be triggered by anxiety, pain, fever, or panic attacks, and may also occur in response to metabolic acidosis via chemoreceptor stimulation.
• Apnea: The cessation of breathing, marked by the absence of respiratory muscle movement. Apnea may be central or obstructive in origin.

Disorders of biomechanics: Mechanical or structural abnormalities can impair ventilation and lead to inefficient gas exchange, requiring targeted interventions.

• Neuromuscular hypoventilation: Respiratory muscle weakness results in slow or shallow breathing, typically worsening during sleep and progressing to type 2 respiratory failure, characterized by hypercapnia and hypoxemia. Causes include amyotrophic lateral sclerosis, diaphragmatic paralysis, Duchenne or Becker muscular dystrophy, Guillain-Barré syndrome, and myasthenia gravis.[11] Management ranges from physiotherapy and noninvasive ventilation to emergency invasive mechanical ventilation.
• Obesity hypoventilation syndrome: Obesity hypoventilation syndrome (OHS) is defined by obesity (body mass index (BMI) of 30 kg/m² or higher) and awake daytime hypercapnia (PaCO₂ of 45 mm Hg or higher) when no other causes of hypoventilation are present. Approximately 8% of adults in the United States meet criteria for morbid obesity, described as a BMI of 40 kg/m² or higher.[12] Among this group, obesity hypoventilation syndrome occurs in 20% to 30% of affected individuals.[13] Patients with obesity hypoventilation syndrome are more likely to require intensive care unit admission than those with similar BMI but normal ventilation.[14] Treatment includes weight loss through diet, exercise, pharmacological therapy, or bariatric surgery. Positive airway pressure ventilation may be necessary to prevent type 2 respiratory failure.
• Obstructive sleep apnea: Recurrent episodes of shallow breathing, snoring, and apnea during sleep are characteristic of obstructive sleep apnea. Patients often present with excessive daytime somnolence and morning headache, and have an increased risk of cardiovascular disease. Obstructive sleep apnea is associated with increased neck circumference and narrowed or collapsible airways. Management includes weight loss and continuous positive airway pressure.[15] 

Cardiorespiratory-mediated abnormalities:  Respiratory symptoms may reflect underlying cardiopulmonary disease, requiring careful assessment to guide therapy.

• Dyspnea: The sensation of difficult or labored breathing, often perceived as air hunger or inadequate airflow. Common causes include respiratory infections, COPD, asthma, venous thromboembolism, interstitial lung disease, pneumothorax, arrhythmia, heart failure, and myocardial ischemia.[16]
• Paroxysmal nocturnal dyspnea: Sudden nighttime shortness of breath that awakens the patient and improves upon sitting upright. Classically associated with pulmonary edema from heart failure, paroxysmal nocturnal dyspnea may also occur in patients with asthma and COPD due to airway narrowing.
• Orthopnea: A common symptom of heart failure. Orthopnea is dyspnea that occurs when lying flat and is relieved by elevation of the upper body.[17]

Centrally mediated abnormalities: Disorders affecting central respiratory control can result in irregular or absent breathing patterns, often signaling severe neurological compromise.

• Central sleep apnea: A temporary cessation of ventilatory output during sleep due to hypocapnia and reduced metabolic drive.[18]
• Biot respiration: Clusters of deep, regular breaths interspersed with periods of apnea due to pontine damage caused by stroke, trauma, uncal herniation, or opioid toxicity.[19]
• Apneustic breathing: Prolonged, gasping inspirations followed by brief, inadequate expirations caused by upper pontine injury, often from stroke or trauma, that signifies severe brain injury with a poor prognosis. Certain central nervous system depressants, such as ketamine, may also cause this pattern of breathing.[20]
• Central neurogenic hyperventilation: Sustained hyperventilation during wakefulness and sleep, typically due to damage of the midbrain or upper pons from head trauma, brain hypoxia, or inadequate cerebral perfusion.[21] 
• Central neurogenic hypoventilation: Medullary respiratory centers fail to respond to stimuli due to head trauma, cerebral hypoxia, or opioid suppression. Historically termed Ondine's curse, affected patients typically experience normal voluntary breathing during wakefulness but loss of automatic ventilatory drive during sleep.[22][23]
• Cushing's triad: Marked by irregular respirations, hypertension, and bradycardia, this presentation represents a physiological response to increased intracranial pressure and indicates impending brain herniation, requiring immediate intervention to reduce intracranial pressure.[24]

Centrally mediated respiratory abnormalities often arise from hypoxic brain injury and require vigilant management to prevent both hyperventilation and hypoventilation. Management may include pharmacological therapy, surgical intervention, or medically induced coma to reduce and control intracranial pressure.[25]

Metabolic and toxin-mediated abnormalities: Metabolic derangements and toxins can alter respiratory patterns, serving as compensatory or pathological responses.

• Kussmaul respiration: Characterized by deep, rapid, and labored breathing, Kussmaul respiration is a compensatory mechanism for metabolic acidosis. This mechanism aids in the excretion of carbon dioxide and in correcting blood pH. Common causes include diabetic ketoacidosis, uremia, and toxic ingestion of alcohols or salicylates.[26] Prompt recognition and treatment are essential to prevent deterioration and enhance survival.

Respiratory patterns in critically ill patients: Severe illness can produce characteristic abnormal respirations, often indicating critical compromise and poor prognosis.

• Agonal breathing: A medical emergency requiring immediate cardiopulmonary resuscitation and advanced life support, agonal breathing manifests as irregular, gasping, or labored respirations, typically resulting from anoxic brain injury or cardiac arrest.[27] 
• Cheyne-Stokes respiration: Cyclical crescendo-decrescendo breathing with intervening apneic periods, which commonly occurs in patients with heart failure and signifies a poor prognosis.[28] Near the end of life, Cheyens-Stokes respiration reflects hypoperfusion and blood gas imbalance in the setting of low cardiac output.[29]

Other Issues

Psychiatric Component

Dysfunctional breathing disorders refer to dyspnea caused by abnormal breathing patterns that occur in the absence of, or secondary to, structural cardiorespiratory disease and organic pathology. Comorbid medical or psychiatric conditions can trigger these disorders, which may also manifest as somatic expressions of psychological distress. Hyperventilation syndrome is the most widely recognized form, characterized by an elevated respiratory rate and resulting respiratory alkalosis. Sigh syndrome involves repeated deep inhalations accompanied by the sensation of being unable to take a full breath.[30] Other abnormal patterns, such as thoracoabdominal asynchrony, paradoxical breathing, and thoracic or abdominal dominance, reflect ineffective breathing mechanics and can exacerbate symptoms of breathlessness. Clinicians establish the diagnosis by excluding alternative pathology and using clinical history supported by validated screening tools, such as the 16-question Nijmegen questionnaire. Management focuses on patient education, reassurance, and retraining of breathing patterns through targeted breathing exercises and behavioral interventions.[31]

Enhancing Healthcare Team Outcomes

Abnormal respirations encompass any deviation from normal rate, rhythm, depth, or breathing effort. Such alterations may arise from dysfunction in the respiratory centers of the brain, neuromuscular weakness, pulmonary or cardiac disease, or metabolic disturbances. These patterns, ranging from bradypnea and tachypnea to hyperventilation, hypoventilation, apnea, and irregular or periodic respirations, often signal underlying physiological or pathological imbalance. Prompt recognition and assessment are essential, as abnormal respirations can indicate early clinical deterioration or life-threatening conditions such as hypoxia, acidosis, or respiratory failure. Careful observation, timely intervention, and accurate interpretation of respiratory patterns are therefore critical components of patient safety and quality care.

Effective management of abnormal respirations requires coordinated effort among clinicians, advanced practice providers, nurses, respiratory therapists, pharmacists, and other allied healthcare professionals. Advanced practitioners and clinicians coordinate diagnostic evaluation and definitive treatment, ensuring care aligns with patient goals and comorbid conditions. Nurses and respiratory therapists play a central role in continuous monitoring and patient education, whereas pharmacists contribute by reviewing medications that may depress or stimulate respiratory drive. Clinicians must integrate assessment skills with evidence-based strategies such as early warning systems, oxygen therapy, and ventilatory support. Clear, structured communication ensures timely escalation and unified decision-making. Regular interprofessional case discussions, simulation training, and shared protocols strengthen teamwork, reduce errors, and enhance both patient outcomes and staff confidence. This collaborative, patient-centered approach promotes early recognition of deterioration, optimizes management, and improves overall healthcare system performance.

Nursing, Allied Health, and Interprofessional Team Interventions

The broader multidisciplinary team delivers essential specialist-specific interventions that optimize patient outcomes. Respiratory therapists play a central role in the diagnosis and management of abnormal respirations. Their interventions include administering oxygen therapy, performing airway clearance and bronchodilator treatments, and managing invasive and noninvasive ventilation. In acute settings, chest physiotherapy enhances lung expansion, secretion clearance, and gas exchange. In outpatient and rehabilitation environments, pulmonary rehabilitation focuses on personalized exercise programs, education, and long-term self-management strategies for patients with chronic respiratory conditions.

Psychologists address the bidirectional relationship between anxiety and breathing patterns. Using cognitive behavioral therapy, breath retraining, and individual or group counseling, they help patients manage the psychological stress associated with dysfunctional breathing.

Pharmacists contribute by performing medication reconciliation, reviewing inhaled and systemic pharmacotherapy for respiratory disorders, and ensuring that treatment aligns with current clinical guidelines. They also promote adherence by educating patients about correct medication use and potential adverse effects.

Speech and language therapists have diagnostic value in upper airway pathology. Through targeted clinical assessments and flexible laryngoscopy, they evaluate vocal cord and laryngeal function to identify abnormalities contributing to disordered breathing.

Nurses provide essential frontline care, initiating and titrating oxygen therapy, administering inhaled and nebulized medications, and monitoring both invasive and noninvasive ventilation systems. In outpatient and community settings, specialist respiratory nurses coordinate ongoing assessment, education, and support for patients with chronic respiratory conditions, ensuring continuity of care and promoting long-term disease management. Effective interprofessional collaboration, clear communication, and role-specific expertise allow the healthcare team to deliver safe, patient-centered care that improves outcomes and enhances respiratory function across the continuum of care.

Nursing, Allied Health, and Interprofessional Team Monitoring

Monitoring vital signs is an essential component of assessing abnormal respiration. Continuous monitoring technologies, ranging from invasive systems in acute care to noninvasive wearable devices, enhance early detection of respiratory compromise across diverse clinical settings. Nursing staff play a pivotal role in reviewing respiratory trends and conducting direct bedside assessments. Their familiarity with patients' baseline respiratory patterns enables early recognition of deterioration and timely escalation to the healthcare team. Any deviation beyond defined parameters constitutes a red flag requiring prompt clinical review.

Clinical practitioners employ various noninvasive tools to assess respiratory function. Pulse oximetry provides real-time measurement of oxygen saturation, reflecting ventilation effectiveness and identifying hypoxemia associated with abnormal breathing. Capnography measures end-tidal carbon dioxide and facilitates early detection of ventilatory insufficiency. In critically ill patients, serial arterial blood gas sampling, often performed by intensive care nurses, provides detailed insight into gas exchange and acid-base status.

Pulmonary function tests, including peak expiratory flow and spirometry, evaluate airway obstruction and lung capacity to help differentiate restrictive from obstructive patterns. Negative inspiratory force testing, conducted by respiratory therapists, assesses respiratory muscle strength, monitors progression in neuromuscular disorders, and guides readiness for ventilator weaning.

Technological advances in respiratory monitoring for both acute and chronic care continue to support the allied healthcare team. Wearable sensors, remote data platforms, smart inhalers, and artificial intelligence–driven analytics enable early detection of deterioration, adherence tracking, and individualized care planning. Integrating these tools across interprofessional teams promotes real-time communication, coordinated decision-making, and holistic care for patients with abnormal respirations.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Horner RL, Bradley TD. Update in sleep and control of ventilation 2006. Am J Respir Crit Care Med. 2007 Mar 01;175(5):426-31. [PubMed: 17303896]

2.

Pleil JD, Ariel Geer Wallace M, Davis MD, Matty CM. The physics of human breathing: flow, timing, volume, and pressure parameters for normal, on-demand, and ventilator respiration. J Breath Res. 2021 Sep 27;15(4) [PMC free article: PMC8672270] [PubMed: 34507310]

3.

Pippalapalli J, Lumb AB. The respiratory system and acid-base disorders. BJA Educ. 2023 Jun;23(6):221-228. [PMC free article: PMC10201398] [PubMed: 37223696]

4.

Cretikos MA, Bellomo R, Hillman K, Chen J, Finfer S, Flabouris A. Respiratory rate: the neglected vital sign. Med J Aust. 2008 Jun 02;188(11):657-9. [PubMed: 18513176]

5.

Deng T, Jing X, Shao L, Wang Y, Fu C, Yu H, Wang X, Zhao X, Kong F, Ji Y, Tian X, He W, Bi S, Shi L, Wang H, Yuan F, Wang S. A Molecularly Defined Medullary Network for Control of Respiratory Homeostasis. Adv Sci (Weinh). 2025 May;12(18):e2412822. [PMC free article: PMC12079440] [PubMed: 40089863]

6.

Moreira TS, Takakura AC, Falquetto B, Ramirez JM, Oliveira LM, Silva PE, Araujo EV. Neuroanatomical and neurochemical organization of brainstem and forebrain circuits involved in breathing regulation. J Neurophysiol. 2025 Apr 01;133(4):1116-1137. [PMC free article: PMC12477829] [PubMed: 40059616]

7.

Goldhill DR, McNarry AF, Mandersloot G, McGinley A. A physiologically-based early warning score for ward patients: the association between score and outcome. Anaesthesia. 2005 Jun;60(6):547-53. [PubMed: 15918825]

8.

Sarkar M, Madabhavi I, Niranjan N, Dogra M. Auscultation of the respiratory system. Ann Thorac Med. 2015 Jul-Sep;10(3):158-68. [PMC free article: PMC4518345] [PubMed: 26229557]

9.

Hanania NA, O'Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019;14:1127-1138. [PMC free article: PMC6538882] [PubMed: 31213793]

10.

Goërtz YMJ, Spruit MA, Van 't Hul AJ, Peters JB, Van Herck M, Nakken N, Djamin RS, Burtin C, Thong MSY, Coors A, Meertens-Kerris Y, Wouters EFM, Prins JB, Franssen FME, Muris JWM, Vanfleteren LEGW, Sprangers MAG, Janssen DJA, Vercoulen JH. Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619878128. [PMC free article: PMC6767724] [PubMed: 31558115]

11.

Paschoal IA, Villalba Wde O, Pereira MC. Chronic respiratory failure in patients with neuromuscular diseases: diagnosis and treatment. J Bras Pneumol. 2007 Jan-Feb;33(1):81-92. [PubMed: 17568873]

12.

Hales CM, Fryar CD, Carroll MD, Freedman DS, Aoki Y, Ogden CL. Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016. JAMA. 2018 Jun 19;319(23):2419-2429. [PMC free article: PMC6583043] [PubMed: 29922829]

13.

Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007 Jun;11(2):117-24. [PubMed: 17187265]

14.

Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest. 2007 Oct;132(4):1322-36. [PubMed: 17934118]

15.

Slowik JM, Sankari A, Collen JF. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Mar 4, 2025. Obstructive Sleep Apnea. [PubMed: 29083619]

16.

Hashmi MF, Modi P, Basit H, Sharma S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 19, 2023. Dyspnea. [PubMed: 29763140]

17.

Mukerji V. Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths; Boston: 1990. [PubMed: 21250057]

18.

Ishikawa O, Oks M. Central Sleep Apnea. Clin Geriatr Med. 2021 Aug;37(3):469-481. [PubMed: 34210451]

19.

Wijdicks EF. Biot's breathing. J Neurol Neurosurg Psychiatry. 2007 May;78(5):512-3. [PMC free article: PMC2117832] [PubMed: 17435185]

20.

Saito Y, Hashimoto T, Iwata H, Takahashi K, Fukumizu M, Sasaki M, Hanaoka S, Sugai K. Apneustic breathing in children with brainstem damage due to hypoxic-ischemic encephalopathy. Dev Med Child Neurol. 1999 Aug;41(8):560-7. [PubMed: 10479045]

21.

Kramer CL, Wijdicks EF. Central neurogenic hyperventilation. Neurology. 2014 Jul 22;83(4):376. [PubMed: 25049304]

22.

Planjar-Prvan M, Krmpotić P, Jergović I, Bielen I. [Central sleep apnea (Ondine's curse syndrome) in medullary infarction]. Acta Med Croatica. 2010 Oct;64(4):297-301. [PubMed: 21688613]

23.

Mellins RB, Balfour HH, Turino GM, Winters RW. Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore). 1970 Nov;49(6):487-504. [PubMed: 5286083]

24.

Wan WH, Ang BT, Wang E. The Cushing Response: a case for a review of its role as a physiological reflex. J Clin Neurosci. 2008 Mar;15(3):223-8. [PubMed: 18182296]

25.

Haddad S, Aldawood AS, Alferayan A, Russell NA, Tamim HM, Arabi YM. Relationship between intracranial pressure monitoring and outcomes in severe traumatic brain injury patients. Anaesth Intensive Care. 2011 Nov;39(6):1043-50. [PubMed: 22165356]

26.

Shahid W, Khan F, Makda A, Kumar V, Memon S, Rizwan A. Diabetic Ketoacidosis: Clinical Characteristics and Precipitating Factors. Cureus. 2020 Oct 04;12(10):e10792. [PMC free article: PMC7606188] [PubMed: 33154858]

27.

Rea TD. Agonal respirations during cardiac arrest. Curr Opin Crit Care. 2005 Jun;11(3):188-91. [PubMed: 15928464]

28.

Cherniack NS, Longobardo GS. Cheyne-Stokes breathing. An instability in physiologic control. N Engl J Med. 1973 May 03;288(18):952-7. [PubMed: 4571351]

29.

Mittal N, Sykes AV, Malhotra A. A review on the treatment of Cheyne Stokes Breathing in patients with congestive heart failure. Sleep Breath. 2023 Oct;27(5):1939-1940. [PMC free article: PMC10404298] [PubMed: 36746869]

30.

Bondarenko J, Burge AT, Bremner J, Webb E, Nakazawa A, Corso SD, Pepin V, Button B, Hew M, Holland AE. Nonpharmacological Interventions for Dysfunctional Breathing in Adults: A Systematic Review. J Allergy Clin Immunol Pract. 2025 Aug;13(8):2062-2074. [PubMed: 40345332]

31.

Boulding R, Stacey R, Niven R, Fowler SJ. Dysfunctional breathing: a review of the literature and proposal for classification. Eur Respir Rev. 2016 Sep;25(141):287-94. [PMC free article: PMC9487208] [PubMed: 27581828]

Disclosure: Rachel Porter declares no relevant financial relationships with ineligible companies.

Disclosure: Derrel Graham declares no relevant financial relationships with ineligible companies.